Sponsor:
Hugh Taylor
Code:
NCT05343572
Conditions
Asherman Syndrome
Atrophic Endometrium
Recurrent Implantation Failure
Eligibility Criteria
Sex: Female
Age: 18 - 40
Healthy Volunteers: Accepted
Interventions
Plerixafor
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-07. This information was provided to ClinicalTrials.gov by Hugh Taylor on 2024-12-20.